Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid.

Details

Language :

English

ISSN :

15257304

Volume :

22

Issue :

3

Database :

Complementary Index

Journal :

Clinical Lung Cancer

Publication Type :

Academic Journal

Accession number :

150825998

Full Text :

https://doi.org/10.1016/j.cllc.2020.06.011